Skip to main content

Table 3 The baseline characteristics of study subjects with three positive components of metabolic syndrome

From: Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study

 

With central obesity

Without central obesity

P

No. of patients

89

44

 

Male gender, n (%)

42 (47.2%)

26 (59.1%)

0.163

Age (years)

50.6±9.6

48.4±7.7

0.004

Smoking (packs/day)

5.5±10.3

4.9±9.6

0.616

Body Mass Index (kg/m2)

27.4±2.8

24.8±2.1

<0.001

Waist circumference (cm)

92.3±8.2

81.2±6.2

<0.001

Systolic BP (mmHg)

138±23

136±22

0.500

Diastolic BP (mmHg)

81±14

81±12

0.889

Fasting glucose (mmol/L)

5.0±0.6

5.1±0.6

0.200

2hr pc glucose (mmol/L)

7.3±1.8

7.9±1.4

0.112

Triglyceride (mmol/L)

1.4±0.8

2.1±0.7

<0.001

HDL cholesterol (mmol/L)

1.1±0.2

0.9±0.2

<0.001

Total cholesterol (mmol/L)

4.8±1.0

4.7±1.2

0.772

LDL cholesterol (mmol/L)

3.2±0.9

3.0±1.1

0.564

HOMA-IR

1.9±1.1

1.9±1.0

0.989

Incidence of diabetes (per 1000person-years)

55.3

43.9

0.792

  1. Abbreviations: 2hr pc glucose= post-challenge plasma glucose level at 120 minutes, BP= blood pressure, HDL= high-density lipoprotein, HOMA-IR= homeostasis model assessment for insulin resistance and LDL= low-density lipoprotein.